share_log

Intelligent Bio Solutions | 3: Initial statement of beneficial ownership of securities-Director Fraser Nicola Marion

Intelligent Bio Solutions | 3: Initial statement of beneficial ownership of securities-Director Fraser Nicola Marion

Intelligent Bio Solutions | 3:首次持股声明-董事 Fraser Nicola Marion
美股SEC公告 ·  06/18 17:33
Moomoo AI 已提取核心信息
Nicola Marion Fraser, a director and 10% owner of Intelligent Bio Solutions Inc., filed an Initial Statement of Beneficial Ownership of Securities with the SEC on June 17, 2024. The Form 3 filing, which is a requirement under Section 16(a) of the Securities Exchange Act of 1934, indicates that Fraser does not beneficially own any non-derivative or derivative securities of the company. The event requiring the statement occurred on June 7, 2024. The filing was completed by Fraser individually and was submitted to the SEC's Washington, D.C. office.
Nicola Marion Fraser, a director and 10% owner of Intelligent Bio Solutions Inc., filed an Initial Statement of Beneficial Ownership of Securities with the SEC on June 17, 2024. The Form 3 filing, which is a requirement under Section 16(a) of the Securities Exchange Act of 1934, indicates that Fraser does not beneficially own any non-derivative or derivative securities of the company. The event requiring the statement occurred on June 7, 2024. The filing was completed by Fraser individually and was submitted to the SEC's Washington, D.C. office.
Nicola Marion Fraser,智能生物解决方案有限公司的董事和10%的股东,在2024年6月17日向美国证券交易委员会提交了一份初步有益所有权报告。这份Form 3申报是《1934年证券交易法》第16(a)条要求的内容,表明Fraser没有获得公司任何非衍生或衍生证券的有益所有权。需要提交报告的事件发生在2024年6月7日。该申报由Fraser个人完成,并提交给SEC的华盛顿特区办事处。
Nicola Marion Fraser,智能生物解决方案有限公司的董事和10%的股东,在2024年6月17日向美国证券交易委员会提交了一份初步有益所有权报告。这份Form 3申报是《1934年证券交易法》第16(a)条要求的内容,表明Fraser没有获得公司任何非衍生或衍生证券的有益所有权。需要提交报告的事件发生在2024年6月7日。该申报由Fraser个人完成,并提交给SEC的华盛顿特区办事处。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息